SCHEMBL30017524

SCHEMBL30017524

CC(C)(C)OC(=O)N1CCC(N)(c2cccnc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.54
NAMPT P43490 5/20 0.51
OPRD1 P41143 1/20 0.49
OPRK1 P41145 1/20 0.49
JAK2 O60674 1/20 0.47
JAK1 P23458 1/20 0.47
CCNA2 P20248 1/20 0.46
CDK2 P24941 1/20 0.46
KIT P10721 1/20 0.46
GBA1 P04062 1/20 0.46
POLB P06746 1/20 0.46
TSHR P16473 2/20 0.45
ALOX15 P16050 1/20 0.45
ATM Q13315 1/20 0.45
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
CYP11B2 P19099 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP3A5 P20815 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633633 1.00 GPR119 (0.54) GPR119NAMPTOPRD1OPRK1JAK2
SCHEMBL2629481 0.86 ALDH1A1 (0.60) GPR119NAMPTOPRD1OPRK1GBA1
SCHEMBL8351248 0.86 GPR119 (0.52) GPR119NAMPTOPRD1OPRK1JAK2
SCHEMBL3326591 0.85 GPR119 (0.51) GPR119NAMPTOPRD1OPRK1JAK2
SCHEMBL23647585 0.85 JAK2 (0.48) GPR119NAMPTOPRD1OPRK1JAK2
SCHEMBL10324681 0.84 TSHR (0.56) GPR119OPRD1OPRK1JAK2JAK1
SCHEMBL3591849 0.84 GPR119 (0.53) GPR119NAMPTOPRD1OPRK1JAK2
SCHEMBL701615 0.83 GPR119 (0.52) GPR119NAMPTOPRD1OPRK1JAK2
SCHEMBL702268 0.83 GPR119 (0.52) GPR119NAMPTOPRD1OPRK1JAK2
Potassium Ion SCHEMBL26633579 0.82 JAK2 (0.46) GPR119NAMPTOPRD1OPRK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114867720-B Heteroaryl derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2024-10-22 CN disclosed
US-20230348467-A1 Heteroaryl Derivative, Preparation Method Therefor, And Use Thereof ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2023-11-02 US disclosed
EP-4092019-A1 HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF Zhejiang Hisun Pharmaceutical Co., Ltd. (CN) 2022-11-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348467-A1 Heteroaryl Derivative, Preparation Method Therefor, And Use Thereof PTPN11, PTPN1, PTPN7 GPR119 616/4885NAMPT 1127/4885OPRD1 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.